Drug reference

Beclometasone with formoterol and glycopyrronium

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 295

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Moderate-to-severe chronic obstructive pulmonary disease ▶BY INHALATION OF AEROSOL ▶Adult: 2 inhalations twice daily

PDF page 295

National Funding Access Decisions

Scottish Medicines Consortium (SMC) decisions The Scottish Medicines Consortium has advised (October 2017) that beclometasone with formoterol and glycopyrronium (Trimbow ®) is accepted for restricted use within NHS Scotland for the maintenance treatment of adults with severe chronic obstructive pulmonary disease.

PDF page 295

Safety

Interactions

→Appendix 1: beta2 agonists. corticosteroids. glycopyrronium

PDF page 295

Breast Feeding

Manufacturer advises avoid—no information available.

PDF page 295

Hepatic Impairment

Manufacturer advises caution in severe impairment (no information available).

PDF page 295

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Pressurised inhalation CAUTIONARY AND ADVISORY LABELS 8, 10 ▶Trimbow (Chiesi Ltd) Formoterol fumarate dihydrate 5 microgram per 1 dose, Glycopyrronium (as Glycopyrronium bromide) 9 microgram per 1 dose, Beclometasone dipropionate 87 microgram per 1 dose Trimbow 87micrograms/dose / 5micrograms/dose / 9micrograms/dose inhaler | 120 dose P £44.50 eiiii F 270

PDF page 295

Dose text by age group

Adult

2 inhalations twice daily

First-line fragment. Read the complete Indications and Dose section above.

PDF page 295

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Beclometasone with formoterol and glycopyrronium

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 295

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Moderate-to-severe chronic obstructive pulmonary disease ▶BY INHALATION OF AEROSOL ▶Adult: 2 inhalations twice daily

PDF page 295

National Funding Access Decisions

PDF page 295

Safety

Interactions

→Appendix 1: beta2 agonists. corticosteroids. glycopyrronium

PDF page 295

Breast Feeding

Manufacturer advises avoid—no information available.

PDF page 295

Hepatic Impairment

Manufacturer advises caution in severe impairment (no information available).

PDF page 295

Dose and formulations

Medicinal Forms

PDF page 295

Dose text by age group

Adult

2 inhalations twice daily

First-line fragment. Read the complete Indications and Dose section above.

PDF page 295

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.